Skip to content
AwardedPOLGoods

„Dostawa leku blinatumomab na potrzeby COZL.” (znak postępowania: COZL/DZP/AS/3411/PN-61/26)

Published
Published 12 June 2026
Deadline
Closed 29 June 2026

Overview

The Lublin Land Cancer Centre procured a supply of the drug blinatumomab for oncological use. The contract was awarded to Amgen Sp. z o.o. on 3 July 2026 for a value of 516,666.67 PLN.

Key details

Country
POL
Status
Awarded
Category
Goods
Procedure
Open
Published
12 June 2026
Deadline
Closed
Classification (CPV)
Various medicinal products

Award outcome

Awarded value
PLN 516,667
Award date
3 July 2026
Contract period
— → 28 June 2027
Winner
  • Amgen Sp. z o.o.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    9 July 2026

  2. Contract Notice

    12 June 2026

Contracting authority

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: „Dostawa leku blinatumomab na potrzeby COZL.” (znak postępowania: COZL/DZP/AS/3411/PN-61/26) — won by Amgen Sp. z o.o. — Skim